Rohan Palanki

Jul 22, 2024 | pubs.rsc.org | Rohan Palanki |Emily Han |Amanda Murray |Rohin Maganti

Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing mRNA-based gene editing platforms have tremendous promise in the treatment of genetic diseases. However, for this potential to be realized in vivo, these nucleic acid cargos must be delivered safely and effectively to cells of interest.